Skip to content

Clinical Observation on the Efficacy of entire colon retention enema with traditional Chinese medicine on extensive ulcerative colitis

Clinical Observation on the Efficacy of entire colon retention enema with traditional Chinese medicine on extensive ulcerative colitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000610
Enrollment
Unknown
Registered
2025-03-28
Start date
2020-08-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ulcerative colitis

Interventions

rectal enema group:rectal enema induced by Compound Qingdai enema
entire colon enema group:entire colon enema induced by Compound Qingdai enema

Sponsors

The First Affiliated Hospital of Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) According to the Consensus Opinions on the Diagnosis and Treatment of Inflammatory Bowel Disease formulated by the Chinese Medical Association in 2018 it meets the diagnostic criteria for active UC; 2) Age 18-80 years old; 3)The patients confirmed by colonoscopy and other examinations as extensive colon type UC; (4) The TCM syndrome of UC is large intestine damp-heat type; 5) Sign informed consent.

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1) Patients who could not complete colonoscopy or difficulty in TET catheterization or enema; 2) Suffering from serious basic diseases such as blood system cardiovascular and cerebrovascular diseases liver and kidney and nervous system diseases and mental disorders; 3) Patients with toxic megacolon; 4) Patients who were treated with drugs that may have affected the observation results; 5) Patients with intolerance to enema during the treatment process or difficulty in actively cooperating with and following the visitors on time; 6)Patients who do not meet the required treatment course change or adjust the treatment plan during the process and personal medical history data is difficult to collect will affect the clinical evaluation of patients.

Design outcomes

Primary

MeasureTime frame
Endoscopic score;

Secondary

MeasureTime frame
Histopathological score;Clinical Symptoms score;Serum disease activity indicators;

Countries

China

Contacts

Public ContactQIN Danping

The First Affiliated Hospital of Zhejiang Chinese Medical University

10464520@qq.com0571-87068001

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026